Company News Hub
Freenome News
No direct newsroom story is tagged to Freenome yet. Use this page with the linked company profile and hub routes to keep the chronology tied to the broader market context.
Coverage Snapshot: Freenome
Freenome is currently mapped as a Personal Healthcare company at the Series E stage, with operating context centered on San Francisco Bay Area, California, USA. The company summary on this route is: Freenome brings accurate and non-invasive disease screening to proactively treat cancer Personal Healthcare Biotech
What's Already Mapped
- Funding context: $254.00M, latest mapped round Series E (Andreessen Horowitz, Founders Fund, $254M Series E in 2024, $2.6B valuation).
- Founder coverage: Freenome Team
- Market lens: Personal Healthcare | Series E | San Francisco Bay Area, California, USA.
- Hiring watch: active role clusters include Open Roles.
Connected Routes
Related topics
Use the story feed below for chronology, then bounce back to the company profile and hub pages when you need peer, geography, or stage-level comparison.
No direct newsroom stories yet
We have not mapped a direct tagged article to Freenome yet. In practice, that usually means the coverage is currently showing up inside broader personal healthcare or market-wide stories rather than on a single company-specific route.
- Start with the company profile for the cleanest summary of current company data.
- Check United States newsroom for geography-specific momentum.
- Compare peers through Personal Healthcare startup pages and Series E funding coverage.